Anthropic's Claude Designs Protein Binders for Scorpion Neurotoxins, Releasing Data as Open Resource

Anthropic's Claude research model has designed protein minibinders that successfully target scorpion neurotoxins, a significant step in addressing the more than 1.2 million annual scorpion stings globally. In collaboration with Citrini Research, Claude generated 318,484 protein designs, with 17 of 211 experimentally tested designs demonstrating binding capabilities against four human-dangerous neurotoxins.

Claude's Role in Protein Design

The research leveraged Anthropic's Claude model to generate a substantial number of protein designs. Over approximately 64 hours and through four follow-up prompts, Claude produced 318,484 distinct protein designs. This extensive generation phase demonstrates the model's capacity for rapid and large-scale molecular design.

Following the AI-driven design phase, 211 of these protein designs were selected for experimental testing. Contract laboratories Adaptyv Bio and Twist Bioscience conducted these tests to evaluate the designs' ability to bind to specific targets. This collaboration highlights a hybrid approach, combining advanced AI conversational AI with traditional biological validation methods.

Promising Binding Results and Open Data Release

Out of the 211 experimentally tested designs, 17 demonstrated successful binding against four specific scorpion neurotoxins known to be dangerous to humans. While these results indicate a promising initial step in identifying potential therapeutic candidates, Anthropic emphasizes that these binders are not yet confirmed as antivenom. Further testing, specifically neutralization of venom in a cellular environment, is required to establish their efficacy as antivenom.

In a move to foster further research and development, Anthropic is making all 211 tested designs and their associated data publicly available. This open resource aims to accelerate scientific progress in the field of antivenom development and protein engineering.

Addressing the Impact of Scorpion Stings

Scorpion stings represent a considerable public health challenge globally. Annually, over 1.2 million people are affected by scorpion stings, leading to more than 3,250 deaths. The development of effective and accessible antivenoms remains a critical need, particularly in regions where these stings are prevalent.

External experts have acknowledged the significance of Anthropic's work. Susana Vázquez Torres of CNIO and Timothy P. Jenkins described the project as a promising first step in leveraging AI for this critical medical application. Their assessment underscores the potential of AI AI news in accelerating drug discovery and development processes.

Conclusion

Anthropic's Claude model has demonstrated its capability in designing protein minibinders against scorpion neurotoxins, yielding 17 successful binders out of 211 tested designs. While these binders show promise, further research is necessary to confirm their antivenom properties. The release of this data as an open resource by Anthropic aims to contribute to global efforts in combating the health risks associated with scorpion stings.

Sources

• How Claude designed protein binders against scorpion neurotoxins \ Anthropic
• huggingface.co
• Claude accelerates protein design and analytical chemistry \ Anthropic
• Claude accelerates protein design and analytical chemistry \ Anthropic
• Models overview - Claude Platform Docs